Mast cells contribute to the resolution of allergic inflammation by releasing resolvin D1.

Autor: Puzzovio PG; Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Institute for Drug Research, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Pahima H; Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Institute for Drug Research, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., George T; Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Institute for Drug Research, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Mankuta D; Department of Obstetrics and Gynecology, Hadassah Hebrew University Medical Center, Jerusalem, Israel., Eliashar R; Department of Otolaryngology / Head and Neck Surgery, Hadassah Hebrew University Medical Center and the Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Tiligada E; Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Institute for Drug Research, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel; Department of Pharmacology, Medical School, National and Kapodistrian University of Athens, Athens, Greece., Levy BD; Pulmonary and Critical Care Medicine, Department of Internal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Levi-Schaffer F; Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Institute for Drug Research, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel. Electronic address: francescal@ekmd.huji.ac.il.

Publikováno v: Pharmacological research [Pharmacol Res] 2023 Mar; Vol. 189, pp. 106691. Date of Electronic Publication: 2023 Feb 10.

Glucocorticoids and COVID-19.

Autor: Bruscoli S; Department of Medicine and Surgery, Section of Pharmacology, University of Perugia, Perugia, Italy., Puzzovio PG; Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Institute for Drug Research, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Zaimi M; Department of Pharmacology, Medical School, National and Kapodistrian University of Athens, Athens, Greece., Tiligada K; Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Institute for Drug Research, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel; Department of Pharmacology, Medical School, National and Kapodistrian University of Athens, Athens, Greece., Levi-Schaffer F; Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Institute for Drug Research, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Riccardi C; Department of Medicine and Surgery, Section of Pharmacology, University of Perugia, Perugia, Italy. Electronic address: carlo.riccardi@unipg.it.

Publikováno v: Pharmacological research [Pharmacol Res] 2022 Nov; Vol. 185, pp. 106511. Date of Electronic Publication: 2022 Oct 13.

Selected recent advances in understanding the role of human mast cells in health and disease.

Autor: Levi-Schaffer F; Pharmacology and Experimental Therapeutics Unit, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel. Electronic address: francescal@ekmd.huji.ac.il., Gibbs BF; Department of Human Medicine, University of Oldenburg, Oldenburg, Germany., Hallgren J; Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden., Pucillo C; Laboratory of Immunology, Department of Medicine, University of Udine, Udine, Italy., Redegeld F; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands., Siebenhaar F; Institute for Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology, ITMP Allergology and Immunology, Berlin, Germany., Vitte J; Aix-Marseille University, IRD, APHM, MEPHI, Marseille, France; IDESP, INSERM UA 11, Montpellier, France., Mezouar S; Aix-Marseille University, IRD, MEPHI, Marseille, France., Michel M; Aix-Marseille University, IRD, APHM, MEPHI, Marseille, France; Immunology Laboratory, CHU Nîmes, Nîmes, France., Puzzovio PG; Pharmacology and Experimental Therapeutics Unit, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Maurer M; Institute for Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology, ITMP Allergology and Immunology, Berlin, Germany. Electronic address: marcus.maurer@charite.de.

Publikováno v: The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2022 Jun; Vol. 149 (6), pp. 1833-1844. Date of Electronic Publication: 2022 Mar 08.

Cromolyn Sodium differentially regulates human mast cell and mouse leukocyte responses to control allergic inflammation.

Autor: Puzzovio PG; Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Institute for Drug Research, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Brüggemann TR; Pulmonary and Critical Care Medicine, Department of Internal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Pahima H; Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Institute for Drug Research, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Mankuta D; Department of Obstetrics and Gynaecology, Hadassah Hebrew University Medical Center, Jerusalem, Israel., Levy BD; Pulmonary and Critical Care Medicine, Department of Internal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Levi-Schaffer F; Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Institute for Drug Research, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel. Electronic address: francescal@ekmd.huji.ac.il.

Publikováno v: Pharmacological research [Pharmacol Res] 2022 Apr; Vol. 178, pp. 106172. Date of Electronic Publication: 2022 Mar 09.

Latest Progresses in Allergic Diseases Biomarkers: Asthma and Atopic Dermatitis.

Autor: Puzzovio PG; Pharmacology and Experimental Therapeutics Unit, Faculty of Medicine, School of Pharmacy, Institute for Drug Research, The Hebrew University of Jerusalem, Jerusalem, Israel., Levi-Schaffer F; Pharmacology and Experimental Therapeutics Unit, Faculty of Medicine, School of Pharmacy, Institute for Drug Research, The Hebrew University of Jerusalem, Jerusalem, Israel.

Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2021 Sep 30; Vol. 12, pp. 747364. Date of Electronic Publication: 2021 Sep 30 (Print Publication: 2021).